EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

Don’t miss our Hot Topics Sessions on immunotherapy, new concepts in childhood asthma, pollution and climate change, and primary to secondary prevention. Also don't miss the Clinical Village during the Congress! You will be able to attend practical demonstrations of different techniques, like skin tests, oral food challenges, management of anaphylaxis, etc. It will only be open on Saturday 6 and Sunday 7! Visit the Congress website to register. The Preliminary Programme is also available.

In the last five years, we have almost doubled in size and even more in our range of activities. We believe that a Constitution describing a more 'open' organisation will form the basis for further development and strengthen the Academy. In this spirit, we are consulting with you to make sure that we all share this vision. We encourage you to review the proposed changes to the Constitution, complete the poll and share your thoughts. The consultation will be open until 10 April and will be in the agenda of the General Assembly in June in Barcelona.

Members of the European Parliament (MEPs), patients and doctors have joined forces in an Interest Group to take actions on allergy and asthma in Europe that was launched on March 25 at the European Parliament. The Secretariat of the Interest Group on Allergies and Asthma will be run by EAACI together with EFA and will work to voice the needs of people living with allergy and asthma. Please read the full press release.

Thank you everyone who attended the 10th Symposium of Experimental Rhinology and Immunology of the Nose, SERIN 2015, in Stockholm.Your Ceritficate of Attendance and CME credits will be sent to ou within the next week. Check out the SERIN page for all the abstracts, photos and much more. We also want to congratulate our Travel Grant and Poster Prize winners.

Abstract submissions for PAAM 2015 from 15 - 17 October are open until 30 April. Submit and be part of the exciting programme. PAAM 2015 will offer new data on primary prevention of food allergy, postgraduate courses on pediatric rhinitis and food allergy, news on immunotherapy in childhood, stimulating Pro/Con session and much more. Please check the preliminary programme for further information.

Patients and doctors urge to put EU air quality policy back on the agenda

Find EAACI in Social Media

Want to keep up to date with all EAACI news and deadlines? Why not follow us on Twitter and Instagram, like our page on Facebook or find us on LinkedIn and Google Plus? You can also post your photos from EAACI events as well as your views and opinions on a range of topics

Innovative treatments to control and identify severe asthma

Athens, Greece. 13 November 2014

Two new studies on the treatment and identification of severe asthma may have found new ways to control and identify this disease. Read more in the Press Release here, also available in SP, GR, DE, FR and IT.

Reducing the incidence of food allergy in children

Dublin, Ireland, 9 October 2014

The frequency of food allergic reactions is greater among children than among adults and up to 17% of the European population may be affected. During FAAM 2014 that took place in October, in Dublin two new studies focusing on the prevention of allergy in children were presented. Read more in the Press Release here, also available in Spanish.

Faster and accurate identification of drugs causing allergic reactions: a great relief for patients

Krakow (Poland), 18 September 2014

Cutaneous adverse drug reactions: Diagnosis of CADR could now improve significantly thanks to a new method developed by a group of researchers led by Dr Grzegorz Porebski, Jagiellonian University, Department of Clinical and Environmental Allergology (Krakow, Poland). Read more in the Press Release here.

Zurich, Switzerland 07.04.2014

– Anaphylaxis is increasingly found in allergic reactions in children, primarily caused by food allergies in this population group: up to 22% of European children have an allergy, with serious reaction to food on the rise1. The severity of its effects, which can be fatal, demands the attention not only of allergologists but of all healthcare professionals. This is one of the most important messages found in advance of the new guidelines on anaphylaxis on which the European Academy of Allergy and Clinical Immunology (EAACI) is currently working.

Berne (Switzerland), April 14th 2014 – Drug Hypersensitivity Reactions (DHRs) affect 7% of the general population and represent a major health problem, as they can be life-threatening and require or prolong hospitalisation. Furthermore, both underdiagnosis (as they are insufficiently detected) and overdiagnosis (due to excessive use of the term “allergy”) are common in clinical practice, and this can lead to the prescription of more expensive or less effective drugs.

EAACI was proud to join the European Chronic Disease Alliance (ECDA) at the first EU Summit on Chronic Diseases in Brussels from April 3-4. ECDA welcomed the Commission’s initiative to organise the Summit, which we hope to be a step towards an EU framework to allow the EU to make a significant impact in reaching the United Nations goal of a 25% reduction in premature mortality from chronic diseases by 2025.

Reflecting the feedback from our recent Membership Benefits Survey we are asking you to "Go green with EAACI" and offering the possibility to opt out from receiving printed versions of Allergy and/or Pediatric Allergy and Immunology by selecting the opt out box(es) at the Membership Profile Management Page.